Loading...
XNAS
MTEX
Market cap10mUSD
Jul 09, Last price  
5.22USD
1D
0.00%
1Q
-7.20%
Jan 2017
-74.29%
Name

Mannatech Inc

Chart & Performance

D1W1MN
XNAS:MTEX chart
P/E
—
P/S
0.09
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-3.43%
Rev. gr., 5y
-6.53%
Revenues
108m
-8.34%
410,069,000412,678,000332,703,000289,705,000228,088,000200,689,000173,447,000177,423,000190,081,000180,267,000180,304,000176,696,000173,558,000157,728,000151,407,000159,762,000137,208,000131,955,000117,866,000108,038,000
Net income
-15m
L
32,390,0006,594,000-12,628,000-17,368,000-10,616,000-20,659,000-1,388,0003,174,0006,496,0005,839,000-586,000-1,787,000-3,886,0003,289,0006,261,0009,842,000-4,490,000-2,239,0002,490,000-15,213,000
CFO
-3m
L
39,912,00017,776,000-19,888,000-10,310,0003,995,000-2,874,000-1,192,0008,562,0009,420,0004,386,000-23,0009,998,000-222,0004,917,0006,030,00010,774,000-2,599,000-2,370,0002,261,000-2,963,000
Dividend
Jun 14, 20230.2 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mannatech, Incorporated operates as a global enterprise focused on health and wellness. The company specializes in the creation, marketing, and distribution of a diverse range of products, including dietary supplements, topical skincare and anti-aging solutions, and items designed for weight management. Its offerings reach consumers primarily through direct sales, complemented by e-commerce platforms and a network marketing approach. Established in 1993, Mannatech maintains its corporate headquarters in Flower Mound, Texas.
URL
https://us.mannatech.com/
IPO date
Feb 16, 1999
Employees
228
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT